AUPH - Aurinia Pharmaceuticals Inc. (AUPH) CEO Peter Greenleaf on Q1 2021 Results - Earnings Call Transcript

Aurinia Pharmaceuticals Inc. (AUPH) Q1 2021 Results Earnings Conference Call May 06, 2021, 5:00 pm ET Company Participants Glenn Schulman - Senior Vice President, Corporate Communications and Investor Relations Peter Greenleaf - Chief Executive Officer, Director Max Colao - Chief Commercial Officer Joe Miller - Chief Financial Officer Neil Solomons - Chief Medical Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Ken Cacciatore - Cowen Joseph Schwartz - SVB Leerink Maury Raycroft - Jefferies Justin Kim - Oppenheimer Ed Arce - H.C. Wainwright David Martin - Bloom Burton Presentation Operator Good afternoon ladies and gentlemen and welcome to Aurinia Pharmaceuticals first quarter 2021 financial results conference event. At this time, all participants are placed on a listen only mode and we will open the floor for your questions and comments after the presentation. It's now my pleasure to turn the floor over to your host, Glenn Schulman. Sir, the

For further details see:

Aurinia Pharmaceuticals Inc. (AUPH) CEO Peter Greenleaf on Q1 2021 Results - Earnings Call Transcript